On 3 June, the official delegation of the European Bank for Reconstruction and Development (EBRD) visited Farmak. The event was held as a part of 5-day visit of EBRD delegation to Ukraine.
12 members, representing a half of the Bank’s shareholders, were in a delegation. This was the most representative delegation of the European Bank for Reconstruction and Development ever to visit Ukraine.
Anton Usov, Senior External Affairs Advisor, EBRD, says, “Farmak has been a client of EBRD for nearly 10 years and, for that time, the Bank has supported two projects to strengthen Farmak’s role as the national manufacturer of new high quality medicinal products, many of which are now imported. For EBRD, cooperation with Farmak was the first experience of financing the pharmaceutical business in Ukraine. Now, it is evident that experience is a success.
Visiting the up-to-date pharmaceutical company, that is developing even in the time when Ukraine faces a complicated situation, was the event of great interest for EBRD shareholders. Moreover, the representatives of EBRD Board of Directors called attention to the management team, mostly consisting of women, that is non-typical practice for Ukraine.
The Company’s plans for future and the current financial standing proved to be valuable to EBRD shareholders. Farmak’s marketing strategy, adjusted in connection with changes of the situation in traditional markets and emergence of opportunities in new markets, proved to be of special interest.
Farmak is the industry leader with strong corporate governance and transparent financial statements. Undoubtedly, BRD will be interested in further cooperation with Farmak”.
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...
On October 30 the next court hearing was held in the case regarding the well-known trademark Corvalol Corvalolum. During the court hearing, after having heard the parties’ arguments and a complete and unbiased analysis of the case-file, the Economic Court ruled to dismiss the claim of Pharmaceutical Firm “Darnitsa” against the Ministry of Economic Deve...
Farmak was granted 7 awards in the contest “Best Corporate Media of Ukraine 2019” held by the Association of Corporate Media of Ukraine. The jury consisted of professionals granted the Grand Prix as the highest award to the corporate newspaper “Farmak Life” and the Company’s website. They were awarded with the title “Best Corpmedia Ukraine […]